Hikma 2025 Preliminary Full Year Results скачать в хорошем качестве

Hikma 2025 Preliminary Full Year Results

Hikma Pharmaceuticals PLC announced its financial results for the year ended 31 December 2025 on 26 February 2026. The live Q&A session featured insights from leadership on portfolio performance, strategic priorities, and key developments that shaped the year. You can now watch the full session on YouTube. #Hikma #FinancialResults #LondonStockExchange #Pharmaceuticals #InvestorRelations LSEG (London Stock Exchange Group) is a diversified international markets infrastructure business —earning our clients’ trust for over 300 years. That legacy of customer-focused excellence ensures that you can rely on our expertise in capital formation, intellectual property and risk and balance sheet management. As global leaders in financial indexing, benchmarking and analytic services, we offer unrivalled access to international capital markets. Our high-performance technology solutions enable companies worldwide to access funds for growth and development. And with our Data & Analytics, Capital Markets and Post Trade divisions, we provide a comprehensive, integrated suite of trusted financial market infrastructure services that help our customers pursue—and achieve—their ambitions. That’s how we make a difference— ensuring people can meet their potential—worldwide. Follow us on LinkedIn (linkedin.com/company/london-stock-exchange-group) and Twitter (@LSEGplc).